Literature DB >> 20186229

Diabetes: Diabetic kidney disease: act now or pay later.

Robert C Atkins, Paul Zimmet.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20186229     DOI： 10.1038/nrneph.2010.10

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Authors:  Ravi Retnakaran; Carole A Cull; Kerensa I Thorne; Amanda I Adler; Rury R Holman
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

3.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

4.  Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.

Authors:  H-H Parving; J B Lewis; M Ravid; G Remuzzi; L G Hunsicker
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

5.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

6.  Limited knowledge of kidney disease in a survey of AusDiab study participants.

Authors:  Sarah L White; Kevan R Polkinghorne; Alan Cass; Jonathan Shaw; Robert C Atkins; Steven J Chadban
Journal:  Med J Aust       Date:  2008-02-18       Impact factor: 7.738

7.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

8.  Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.

Authors:  Sophia Zoungas; Bastiaan E de Galan; Toshiharu Ninomiya; Diederick Grobbee; Pavel Hamet; Simon Heller; Stephen MacMahon; Michel Marre; Bruce Neal; Anushka Patel; Mark Woodward; John Chalmers; Alan Cass; Paul Glasziou; Stephen Harrap; Liu Lisheng; Guiseppe Mancia; Avinesh Pillai; Neil Poulter; Vlado Perkovic; Florence Travert
Journal:  Diabetes Care       Date:  2009-08-03       Impact factor: 19.112
  8 in total
  7 in total

Review 1.  World Kidney Day 2011: protect your kidneys, save your heart.

Authors:  William G Couser; Miguel C Riella
Journal:  Pediatr Nephrol       Date:  2011-01-20       Impact factor: 3.714

2.  Rack1 regulates pro-inflammatory cytokines by NF-κB in diabetic nephropathy.

Authors:  Keqian Wu; Rui Peng; Qiuyu Mu; Yongxue Jiang; Jingshou Chen; Rui Ming; Jie Zhao; Zheng Zhang; Yan Sun
Journal:  Open Med (Wars)       Date:  2022-05-26

3.  World Kidney Day 2011 - Protect your kidneys, save your heart.

Authors:  William G Couser; Miguel C Riella
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

4.  Nutritional systems biology of type 2 diabetes.

Authors:  Yuqi Zhao; Rio Elizabeth Barrere-Cain; Xia Yang
Journal:  Genes Nutr       Date:  2015-07-24       Impact factor: 5.523

5.  Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects.

Authors:  Keisuke Ishizawa; Yuki Izawa-Ishizawa; Noriko Yamano; Maki Urushihara; Takumi Sakurada; Masaki Imanishi; Shoko Fujii; Asami Nuno; Licht Miyamoto; Yoshitaka Kihira; Yasumasa Ikeda; Shoji Kagami; Hiroyuki Kobori; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice.

Authors:  Mi Jin Kim; Na Young Kim; Yun A Jung; Seunghyeong Lee; Gwon Soo Jung; Jung Guk Kim; In Kyu Lee; Sungwoo Lee; Yeon Kyung Choi; Keun Gyu Park
Journal:  Diabetes Metab J       Date:  2019-10-31       Impact factor: 5.376

7.  World kidney day 2011: protect your kidneys, save your heart.

Authors:  Sara Martin; W G Couser; M C Riella
Journal:  Int J Organ Transplant Med       Date:  2011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.